Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04547023 · ClinicalTrials.gov registry record · NA
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
A NA study of Gestational Diabetes and Pregnancy in Diabetic, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04547023: Completed NA study of Gestational Diabetes and Pregnancy in Diabetic, sponsored by Stanford University.
NCT04547023 is a NA study of Gestational Diabetes and Pregnancy in Diabetic that has completed, run by Stanford University. The registered enrollment target is 200 participants, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04547023, a NA study of Gestational Diabetes and Pregnancy in Diabetic, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Studies suggest that the timing interval between oral intake and the 1-hour gestational diabetes screen may have a significant impact on gestational diabetes screening glucose levels. The investigators plan to conduct a prospective randomized trial comparing a 6-hour fast versus liberal oral intake within 2 hours prior to the glucose tolerance test in pregnancy in order to evaluate the effect of the fasting versus the fed state on routine gestational diabetes screening results.
Primary Outcome
Number of positive GDM screen (\>= 140 mg/dL) on the 1 hour 50-g oral glucose tolerance test conducted between 24-28 weeks gestation This outcome was assessed in pregnant participants.
Conditions Studied
Interventions
- BEHAVIORAL Fasting before gestational diabetes screen
- BEHAVIORAL Per oral intake of food and drink
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT04547023 record still lists
NCT04547023 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 317-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (37% lower).
The record links to 4 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Fasting before gestational diabetes screen is the first listed.
NCT04547023 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04547023 about?
NCT04547023 is a clinical study titled "Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy". Studies suggest that the timing interval between oral intake and the 1-hour gestational diabetes screen may have a significant impact on gestational diabetes screening glucose levels. The investigators plan to conduct a prospective randomized trial comparing a 6-hour fast versus liberal oral intake ...
What is the current status of trial NCT04547023?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2020-11-02. Estimated completion is 2021-11-01.
What conditions does trial NCT04547023 study?
This clinical trial studies the following conditions: Gestational Diabetes, Pregnancy in Diabetic, Glucose, High Blood, Diagnoses Disease.
What interventions are being tested in trial NCT04547023?
The interventions under investigation include: Fasting before gestational diabetes screen (BEHAVIORAL), Per oral intake of food and drink (BEHAVIORAL).
Who is sponsoring clinical trial NCT04547023?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04547023 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04547023's enrollment target sits among peer trials
200 13th of 41 higher than 28 of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI